摘要
胰腺导管内乳头状粘液瘤(IPMN)是胰腺的癌前病变之一,目前关于IPMN的治疗及随访策略存在一定争议,核心问题在于术前对病灶性质及恶变风险的准确评估。高质量循证医学证据的积累和高效评估手段的开发是建立规范化IPMN评估决策体系、提升患者临床获益的必由之路。本综述旨在对最新指南及代表性文献中关于手术评估标准的共识与争议进行归纳,并结合相关评估技术进一步展望IPMN诊疗决策的发展方向。
Intraductal papillary mucinous neoplasm(IPMN)is one of the precancerous lesions of the pancreas.Currently there is controversial over the management and follow-up strategy of IPMN,including the timing of surgery.The core problem lies in the accurate preoperative assessment of the nature of the lesions and the risk of malignant transformation.Cumulation of high-quality evidence and development of efficient evaluation methods are vital for the establishment of standardized decision-making system and the improvement of clinical benefits to patients.This review aims to summarize the consensus and controversies on surgical evaluation standards in the latest guidelines and representative literatures,and to look forward to the development direction of IPMN diagnosis and treatment decisions in combination with the progress of related evaluation techniques.
作者
王砚伟
崔成昊
梁雨荣
Wang Yanwei;Cui Chenghao;Liang Yurong(Medical School of Chinese PLA,Beijing 100853,China;Faculty of Hepato-Pancreato-Biliary Surgery,Chinese PLA General Hospital,Institute of Hepatobiliary Surgery of Chinese PLA,Key Laboratory of Digital Hepatobiliary Surgery of PLA,Beijing 100853,China)
出处
《中华肝胆外科杂志》
CAS
CSCD
北大核心
2023年第4期316-320,共5页
Chinese Journal of Hepatobiliary Surgery
关键词
胰腺导管内肿瘤
临床评估
诊疗决策
Pancreatic intraductal neoplasms
Clinical evaluation
Decision-making
